MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

908 Devices Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$11.43+0.17 (+1.51%)

Close on Oct 19, 2026

Market cap: $431.23M
P/E (TTM): –
Dividend yield: –

Dividends

908 Devices has not reported a dividend

No dividend per share appears in 908 Devices's annual filings since fiscal 2019.

Where these numbers come from

Parsed from the XBRL in 908 Devices's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MASS.

Revenue growth13.4% · median 9.1%

Gross margin52.2% · median 48.0%

Operating margin-64.0% · median -21.6%

Net margin-57.0% · median -51.3%

Company	Revenue	Growth
CTKB	$206.71M	+5.4%
QTRX	$153.41M	+22.0%
HBIO	$87.81M	-1.1%
MASS	$60.84M	+13.4%
RPID	$35.18M	+16.1%
LCTC	$9.27M	+9.1%

Company

Next earnings (est.): Nov 9, 2026, before open
Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 172
Held by institutions: 70.2%
Auditor: PricewaterhouseCoopers, LLP
SEC CIK: 1555279

Advertisement
300 × 250